- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
Patent holdings for IPC class A61K 31/44
Total number of patents in this class: 7532
10-year publication summary
|
494
|
432
|
476
|
448
|
404
|
363
|
380
|
381
|
356
|
122
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3732 |
96 |
| Bristol-myers Squibb Company | 4815 |
88 |
| Merck Sharp & Dohme Corp. | 2184 |
86 |
| Boehringer Ingelheim International GmbH | 4496 |
74 |
| Novartis AG | 10341 |
70 |
| The Regents of the University of California | 20587 |
68 |
| Arcutis Biotherapeutics, Inc. | 119 |
58 |
| F. Hoffmann-La Roche AG | 7841 |
49 |
| Vertex Pharmaceuticals Incorporated | 1595 |
48 |
| Chiesi Farmaceutici S.p.A. | 959 |
46 |
| Takeda Pharmaceutical Company Limited | 2716 |
43 |
| Hoffmann-La Roche Inc. | 3718 |
37 |
| Pfizer Inc. | 3370 |
33 |
| Abbvie Inc. | 1840 |
33 |
| Merck Patent GmbH | 5669 |
32 |
| Board of Regents, The University of Texas System | 6062 |
32 |
| Janssen Pharmaceutica N.V. | 3226 |
31 |
| Gilead Sciences, Inc. | 2190 |
31 |
| Vanderbilt University | 1982 |
31 |
| Centre National de La Recherche Scientifique | 10895 |
30 |
| Other owners | 6516 |